What is NDC 71335-2586?

71335-2586 is the product NDC for Pentoxifylline, Pentoxifylline 400 mg/1 tablet, extended release, listed with the FDA by Bryant Ranch Prepack. It has 3 package NDCs, shown above in 10- and 11-digit form.

Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Pentoxifylline?

6 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Pentoxifylline NDC 71335-2586 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)71335-2586Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71335-2586Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71335-2586-1	71335258601	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2586-1)Marketed from Apr 7, 2025
71335-2586-2	71335258602	60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2586-2)Marketed from Apr 7, 2025
71335-2586-3	71335258603	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2586-3)Marketed from Apr 7, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Pentoxifylline
Generic name (nonproprietary): pentoxifylline
Active ingredients: Pentoxifylline — 400 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Bryant Ranch PrepackNDC labeler code 71335
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 074425
Marketing start: Jun 11, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Hematologic Activity Alteration (Physiologic effect)
Identifiers: Product ID 71335-2586_7ee0f77c-2c3e-44fe-9acf-a540e98bd641SPL ID 7ee0f77c-2c3e-44fe-9acf-a540e98bd641SPL set ID c3ad4fb4-8995-46ab-86e9-7ec67ef607f9RxCUI 312301UNII SD6QCT3TSU
Pharmacologic class: Blood Viscosity Reducer

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335258601 followed by a unit qualifier and the quantity

Package 71335-2586-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 7, 2025.

Indications (excerpt from the label)

INDICATIONS & USAGE Pentoxifylline extended-release tablets are indicated for the treatment of patients with intermittent claudication on the basis of chronic occlusive arterial disease of the limbs. Pentoxifylline extended-release tablets can improve function and symptoms but is not intended to replace more definitive therapy, such as surgical bypass, or removal of arterial obstructions when treating peripheral vascular disease.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71335-2586

What is NDC 71335-2586?: 71335-2586 is the product NDC for Pentoxifylline, Pentoxifylline 400 mg/1 tablet, extended release, listed with the FDA by Bryant Ranch Prepack. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Pentoxifylline.
What is the active ingredient?: Pentoxifylline.
Who is the labeler?: Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Pentoxifylline?: 6 other product NDCs are listed under this name. See all Pentoxifylline NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Pentoxifylline NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	Rising Pharma Holdings, Inc.	16571-856	16571-0856-0116571-0856-0516571-0856-11+2 more
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	ANI Pharmaceuticals, Inc.	70954-668	70954-0668-1070954-0668-20
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	NCS HealthCare of KY, LLC dba Vangard Labs	0615-8511	00615-8511-39
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	63629-2910	63629-2910-0163629-2910-0263629-2910-03
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	Apotex Corp.	60505-0033	60505-0033-0660505-0033-07
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	Major Pharmaceuticals	0904-5448	00904-5448-61

Other NDCs under ANDA 074425

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 074425
Product	Strength	Form · route	Labeler	Product NDC
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	Rising Pharma Holdings, Inc.	16571-856